Eric Bjerkholt, CHIEF FINANCIAL OFFICER at Mirum Pharmaceuticals, Inc. (MIRM), sold 19,156 shares at $76.01 ($1.5M) on 2025-09-12, disclosed to the SEC on 2025-09-12.
Open-market sale of $1.5M MIRM by CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.01 | 9,578 | $728K | 50.0% |
| 2 | $76.01 | 9,578 | $728K | 50.0% |
| Total | $76.01 avg | 19,156 | $1.5M | 100% |
| Filing → |
| MIRM | SELL | 2026-07-08 | $611K | — | Filing → |
| CERS | SELL | 2026-06-11 | $53K | — | Filing → |
| MIRM | SELL | 2026-06-09 | $469K | — | Filing → |